Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors

Completed · Not applicable

Conditions studied: Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT

In brief

This randomized study will compare a personalized Survivorship Care Plan (SCP) template with usual care (no SCP). The investigators hypothesize that the personalized SCP that incorporates patient specific treatment exposures and provides a framework for long term followup based on those exposures and subsequent risks for late complications will enhance patient survivorship confidence in knowledge, increase adherence to recommended healthcare, improve health behaviors and reduce HCT-related emotional distress.

Key facts

Study ID

NCT02200133

Run by

Center for International Blood and Marrow Transplant Research

People needed

495

Starts

2015-04-01

Expected to finish

2017-04-01

Last updated by the study team

2017-09-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (≥ 18 years at time of allogeneic HCT recipient at participating transplant centers)
• Survival 1-2 years after most recent HCT with no evidence of relapse, disease progression, or secondary cancer on last follow-up
• All diagnoses will be eligible
• All transplant types will be eligible (autologous or allogeneic related or unrelated)
• All graft sources will be eligible (bone marrow, peripheral blood or umbilical cord blood)
• All conditioning regimens will be eligible (in case of allogeneic HCT, patient could have received myeloablative or non-myeloablative/reduced-intensity conditioning)
• Patient may have received more than one HCT
• Patient must be proficient in English (written and spoken) to complete study assessments
• Patient must have a valid mailing address within the United States to receive study materials
• Signed informed consent form from patient

You may not qualify if…

• Patients who have received their transplant at a different transplant center will not be eligible for the study

Where it is running

• Mayo Clinic — Scottsdale, Arizona, United States
• University of Florida, Shands Hospital — Gainesville, Florida, United States
• Loyola Medical Center — Maywood, Illinois, United States
• University of Kansas Cancer Center — Westwood, Kansas, United States
• University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
• Karmanos Cancer Institute — Detroit, Michigan, United States
• University of Minnesota Medical Center — Minneapolis, Minnesota, United States
• Mayo Clinic Rochester — Rochester, Minnesota, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• UNC Chapel Hill — Chapel Hill, North Carolina, United States
• University Hospitals Case Medical Center — Cleveland, Ohio, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Ohio State University — Columbus, Ohio, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
• Baylor University Medical Center — Dallas, Texas, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.